| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in Diagnosis and Management of Diffuse Large B-cell Lymphoma
|
Cabanillas, Fernando
|
|
2017
|
17 |
12 |
p. 783-796
|
artikel
|
| 2 |
A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia
|
Mirza, Abu-Sayeef
|
|
2017
|
17 |
12 |
p. 902-907
|
artikel
|
| 3 |
Cardiovascular Events After Exposure to Nilotinib in Chronic Myeloid Leukemia: Long-term Follow-up
|
Aghel, Nazanin
|
|
2017
|
17 |
12 |
p. 870-878.e1
|
artikel
|
| 4 |
Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients
|
Ely, Scott
|
|
2017
|
17 |
12 |
p. 825-833
|
artikel
|
| 5 |
Characteristics of Vitamin B12 Deficiency in Patients With Plasma Cell Disorders
|
Braschi, Caitlyn
|
|
2017
|
17 |
12 |
p. e65-e69
|
artikel
|
| 6 |
Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: A Narrative Review
|
Mato, Anthony R.
|
|
2017
|
17 |
12 |
p. 852-856
|
artikel
|
| 7 |
Cutaneous Adverse Events of Targeted Therapies for Hematolymphoid Malignancies
|
Ransohoff, Julia D.
|
|
2017
|
17 |
12 |
p. 834-851
|
artikel
|
| 8 |
Editorial Board
|
|
|
2017
|
17 |
12 |
p. A4
|
artikel
|
| 9 |
Generic Imatinib Therapy Among Jordanians: An Observational Assessment of Efficacy and Safety in Routine Clinical Practice
|
Awidi, Abdalla
|
|
2017
|
17 |
12 |
p. e55-e61
|
artikel
|
| 10 |
Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era
|
Mustafa Ali, Moaath
|
|
2017
|
17 |
12 |
p. 797-803
|
artikel
|
| 11 |
High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System Involvement
|
Qualls, David
|
|
2017
|
17 |
12 |
p. 884-888
|
artikel
|
| 12 |
Impact of Synchronous Multiple Primary Malignant Tumors on Newly Diagnosed Hematological Malignancies
|
Nishiwaki, Satoshi
|
|
2017
|
17 |
12 |
p. e79-e85
|
artikel
|
| 13 |
Improving Provision of Care for Long-term Survivors of Lymphoma
|
Ciavarella, Sabino
|
|
2017
|
17 |
12 |
p. e1-e9
|
artikel
|
| 14 |
Increased Mortality Among Patients With Acute Leukemia Admitted on Weekends Compared to Weekdays
|
Parikh, Kaushal
|
|
2017
|
17 |
12 |
p. e33-e43
|
artikel
|
| 15 |
Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population
|
Madanat, Yazan F.
|
|
2017
|
17 |
12 |
p. 857-862
|
artikel
|
| 16 |
Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Real-world Case Series of Consecutive Patients Treated by a Single Multidisciplinary Team in the East of England From 1999 to 2015
|
Griffin, Jessica C.
|
|
2017
|
17 |
12 |
p. e75-e78
|
artikel
|
| 17 |
Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec
|
Eskazan, Ahmet Emre
|
|
2017
|
17 |
12 |
p. 804-811
|
artikel
|
| 18 |
Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib
|
Kota, Vamsi K.
|
|
2017
|
17 |
12 |
p. e71-e73
|
artikel
|
| 19 |
Pegylated GCSF Can Be Used With First-Line da-EPOCH-R Without Compromising Dose Intensity, Safety, or Efficacy
|
Reddy, Prathima
|
|
2017
|
17 |
12 |
p. e87-e90
|
artikel
|
| 20 |
Peripheral Blood Lymphocyte-to-Monocyte Ratio at Relapse Predicts Outcome for Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in the Rituximab Era
|
Katoh, Daisuke
|
|
2017
|
17 |
12 |
p. e91-e97
|
artikel
|
| 21 |
Results of Upfront Therapy for Marginal Zone Lymphoma
|
Ortega, José L.
|
|
2017
|
17 |
12 |
p. 879-883
|
artikel
|
| 22 |
Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia
|
Assi, Rita
|
|
2017
|
17 |
12 |
p. 897-901
|
artikel
|
| 23 |
Sepsis and Acute Myeloid Leukemia: A Population-Level Study of Comparative Outcomes of Patients Discharged From Texas Hospitals
|
Malik, Imrana A.
|
|
2017
|
17 |
12 |
p. e27-e32
|
artikel
|
| 24 |
Stability of Spinal Bone Lesions in Patients With Multiple Myeloma After Radiotherapy—A Retrospective Analysis of 130 Cases
|
Lang, Kristin
|
|
2017
|
17 |
12 |
p. e99-e107
|
artikel
|
| 25 |
Table of Contents
|
|
|
2017
|
17 |
12 |
p. A5-A7, A12-A13
|
artikel
|
| 26 |
The Clinical Spectrum of Hepatic Manifestations in Chronic Lymphocytic Leukemia
|
Kreiniz, Natalia
|
|
2017
|
17 |
12 |
p. 863-869
|
artikel
|
| 27 |
The Role of Radiation in All Stages of Nodular Lymphocytic Predominant Hodgkin Lymphoma
|
Odei, Bismarck
|
|
2017
|
17 |
12 |
p. 819-824
|
artikel
|
| 28 |
The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib Approval
|
Kuykendall, Andrew T.
|
|
2017
|
17 |
12 |
p. e45-e53
|
artikel
|
| 29 |
Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
|
Ammann, Eric M.
|
|
2017
|
17 |
12 |
p. e11-e25
|
artikel
|
| 30 |
Treatment Patterns and Outcomes in Early-stage Hodgkin Lymphoma in the Elderly: A National Cancer Database Analysis
|
Goyal, Gaurav
|
|
2017
|
17 |
12 |
p. 812-818
|
artikel
|
| 31 |
Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens
|
Hecht, Anna
|
|
2017
|
17 |
12 |
p. 889-896.e5
|
artikel
|
| 32 |
Vascular Adverse Events During Long-term Nilotinib Therapy in Patients With Chronic Myeloid Leukemia
|
Eskazan, Ahmet Emre
|
|
2017
|
17 |
12 |
p. e63-e64
|
artikel
|
Tijdschrift beschrijving